FDA Approves Vivus' EvaMist
Vivus Inc. (VVUS) announced FDA approval of its EvaMist menopausal spray. The stock price rose 25 cents to close at $5.75.
posted by FC Market News at 9:14 AM
posted by FC Market News at 9:14 AM
0 Comments:
Post a Comment
<< Home